Evidence map›Paper›PMID 28899450›Full record

ArticleInternational psychogeriatrics2017

Joining forces to prevent dementia: The International Research Network On Dementia Prevention (IRNDP).

Kaarin J Anstey, Ruth Peters, Linda Clare, Nicola T Lautenschlager, Hiroko H Dodge, Deborah E Barnes, Suzana Shahar, Henry Brodaty, Glenn Rees

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in International psychogeriatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Scanning resources to build an international nursing knowledge network.International journal of nursing sciences · 2024
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kaarin J AnsteyCentre for Research on Ageing,Health & Wellbeing,ANU College of Health and Medicine,Australian National University,Canberra,Australia.
Ruth PetersCentre for Research on Ageing,Health & Wellbeing,ANU College of Health and Medicine,Australian National University,Canberra,Australia.ORCID 0000-0003-0148-3617
Linda ClareCentre for Research in Ageing and Cognitive Health (REACH),University of Exeter,Exeter,UK.
Nicola T LautenschlagerAcademic Unit for Psychiatry of Old Age,Department of Psychiatry,The University of Melbourne & North Western Mental Health,Melbourne Health,Melbourne,Australia.
Hiroko H DodgeDepartment of Neurology,Layton Aging and Alzheimer's Disease Center,Oregon Health & Science University,Portland,OR,USA.
Deborah E BarnesSchool of Medicine,University of California San Francisco,USA.
Suzana ShaharCentre of Community Rehabilitation and Aging,Universiti Kebangsaan,Selangor,Malaysia.
Henry BrodatyCentre for Healthy Brain Ageing,School of Psychiatry,University of New South Wales,Sydney,New South Wales,Australia.
Glenn ReesAlzheimer's Disease International,London,UK.

Funding

Outreach, Recruitment and Education CoreP30AG008017 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KAYE, JEFFREY A · 1990 to 2019
$27.7M
Michigan Alzheimer's Disease Core CenterP30AG053760 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 2016 to 2020
$10.1M
Conversational Engagement as a Means to Delay Onset AD: Phase II Administrative SupplementR01AG051628 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI DODGE, HIROKO HAYAMA · 2016 to 2020
$4.8M
Web-enabled social interaction to delay cognitive decline among seniors with MCI: Phase I Administrative SupplementR01AG056102 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI DODGE, HIROKO HAYAMA · 2017 to 2021
$4.6M
NIA NIH HHS P30 AG008017NIA NIH HHS P30 AG053760NIA NIH HHS R01 AG051628NIA NIH HHS R01 AG056102
6 · The paper itself

Abstract

Dementia is a neurodegenerative disorder with global impact, with the largest proportion of cases occurring in low- and middle-income countries. It is estimated that there are 46.8 million cases globally with approximately 10 million new cases each year or a new case occurring every 3 sec (Prince et al., 2015). For comparison there are 36.7 million HIV cases with an estimated 2 million new cases each year (WHO, 2017). The rise in dementia prevalence is largely due to population ageing, with the oldest being at highest risk. To date there are no diseases modifying medications for Alzheimer's disease or the other causes of dementia. Academics and research groups are increasingly focused on prevention or delay of dementia (Brayne and Miller, 2017) and a number of organizations now prioritize dementia, indicating a strong and coherent international effort to address this problem. Examples include the World Health Organisation (WHO), which has established a Global Dementia Observatory; the World Dementia Council; the Organisation for Economic Co-operation and Development (OECD); the U.S. National Alzheimer's Project Act (NAPA); and the Global Council on Brain Health.

Indexed as

International CooperationDementiaHealth PrioritiesHealth Services ResearchHIV InfectionsHumans

Identifiers

PMID28899450
PMCPMC5873600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.